# MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes

> **NCT04534543** · NA · RECRUITING · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 70 (estimated)

## Conditions studied

- Gastrointestinal Cancer Metastatic

## Interventions

- **RADIATION:** MRI/Spectroscopy

## Key facts

- **NCT ID:** NCT04534543
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-15
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534543, "MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04534543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*